Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 4
2004 2
2008 2
2009 1
2010 2
2011 2
2012 2
2014 1
2015 2
2017 3
2018 6
2019 9
2020 6
2021 6
2022 6
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Prophylactic tenofovir alafenamide for hepatitis B virus reactivation and reactivation-related hepatitis.
Suda G, Baba M, Yamamoto Y, Sho T, Ogawa K, Kimura M, Hosoda S, Yoshida S, Kubo A, Fu Q, Yang Z, Tokuchi Y, Kitagataya T, Maehara O, Ohnishi S, Yamada R, Ohara M, Kawagishi N, Natsuizaka M, Nakai M, Morikawa K, Furuya K, Suzuki K, Izumi T, Meguro T, Terashita K, Ito J, Kobayashi T, Tsunematsu I, Sakamoto N. Suda G, et al. Among authors: baba m. J Med Virol. 2023 Feb;95(2):e28452. doi: 10.1002/jmv.28452. J Med Virol. 2023. PMID: 36597900
Factors Associated with Breakthrough Fungemia Caused by Candida, Trichosporon, or Fusarium Species in Patients with Hematological Disorders.
Kimura M, Asano-Mori Y, Sakoh T, Abe M, Ueno K, Hoshino Y, Nakamura S, Umeyama T, Yamagoe S, Miyazaki Y, Baba M, Okada C, Ogura S, Mitsuki T, Yamaguchi K, Yuasa M, Kaji D, Kageyama K, Nishida A, Taya Y, Ishiwata K, Takagi S, Yamamoto H, Yamamoto G, Uchida N, Wake A, Taniguchi S, Araoka H. Kimura M, et al. Among authors: baba m. Antimicrob Agents Chemother. 2022 Mar 15;66(3):e0208121. doi: 10.1128/AAC.02081-21. Epub 2022 Jan 18. Antimicrob Agents Chemother. 2022. PMID: 35041512 Free PMC article.
Low Baseline CXCL9 Predicts Early Progressive Disease in Unresectable HCC with Atezolizumab Plus Bevacizumab Treatment.
Hosoda S, Suda G, Sho T, Ogawa K, Kimura M, Yang Z, Yoshida S, Kubo A, Tokuchi Y, Kitagataya T, Maehara O, Ohnishi S, Nakamura A, Yamada R, Ohara M, Kawagishi N, Natsuizaka M, Nakai M, Morikawa K, Furuya K, Baba M, Yamamoto Y, Suzuki K, Izumi T, Meguro T, Terashita K, Ito J, Miyagishima T, Sakamoto N. Hosoda S, et al. Among authors: baba m. Liver Cancer. 2022 Oct 31;12(2):156-170. doi: 10.1159/000527759. eCollection 2023 Jun. Liver Cancer. 2022. PMID: 37325489 Free PMC article.
Helicobacter fennelliae Localization to Diffuse Areas of Human Intestine, Japan.
Sakoh T, Miyajima E, Endo Y, Kono K, Sato J, Haraguchi M, Ogura S, Morishima M, Ishida K, Ochiai Y, Hoteya S, Takazawa Y, Baba M, Araoka H. Sakoh T, et al. Among authors: baba m. Emerg Infect Dis. 2024 Jan;30(1):129-132. doi: 10.3201/eid3001.231049. Emerg Infect Dis. 2024. PMID: 38147044 Free PMC article.
[Hepatitis A].
Baba M, Hasegawa H. Baba M, et al. Nihon Rinsho. 2003 Feb;61 Suppl 2:229-35. Nihon Rinsho. 2003. PMID: 12722219 Review. Japanese. No abstract available.
[Hepatitis A].
Baba M, Hasegawa H. Baba M, et al. Nihon Rinsho. 2002 Jan;60 Suppl 1:200-8. Nihon Rinsho. 2002. PMID: 11838115 Review. Japanese. No abstract available.
Serum IL-1β predicts de novo hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C, not during anti-cancer/immunosuppressive therapy.
Kawagishi N, Suda G, Sakamori R, Matsui T, Onozawa M, Yang Z, Yoshida S, Ohara M, Kimura M, Kubo A, Maehara O, Fu Q, Hosoda S, Tokuchi Y, Suzuki K, Nakai M, Sho T, Morikawa K, Natsuizaka M, Ogawa K, Sakai H, Ohnishi S, Baba M, Takehara T, Sakamoto N. Kawagishi N, et al. Among authors: baba m. Sci Rep. 2022 Oct 7;12(1):16800. doi: 10.1038/s41598-022-21315-z. Sci Rep. 2022. PMID: 36207368 Free PMC article.
50 results